<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02343237</url>
  </required_header>
  <id_info>
    <org_study_id>P130605</org_study_id>
    <nct_id>NCT02343237</nct_id>
  </id_info>
  <brief_title>Osteopathic Medicine in Fibromyalgia Syndrome</brief_title>
  <acronym>FIBROPATHIC</acronym>
  <official_title>A Multicenter, Randomized Study, Against Credible Factitious Intervention That Evaluates the Interest of Osteopathic Medicine in the Management of Fibromyalgia Syndrome</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assistance Publique - Hôpitaux de Paris</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assistance Publique - Hôpitaux de Paris</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the analgesic effects of a 6 weeks osteopathic&#xD;
      treatment on patients with fibromyalgia.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      An osteopathic treatment could have a positive and durable effect on pain and quality of life&#xD;
      on patients with fibromyalgia.&#xD;
&#xD;
      This technique, in addition to the standard treatment in a multidisciplinary care center,&#xD;
      could be efficient by releasing muscle tension.&#xD;
&#xD;
      This is a 24 months multicenter (2 recruiting centers, 1 care center), randomized, and&#xD;
      placebo-controlled study. The purpose is to evaluate the analgesic efficacy of a 6 weeks&#xD;
      osteopathic treatment compared to a 6 week standard treatment on patients with fibromyalgia.&#xD;
      It includes 6 osteopathic/standard sessions of 20 minutes (of one week apart), a follow-up at&#xD;
      3 months, 6 months and 12 months.&#xD;
&#xD;
      The primary aim of this study is to evaluate the pain after each osteopathic session, at the&#xD;
      end of the 6 weeks treatment, and after each visit, judging by the patient's pain measured by&#xD;
      a numeric scale (EVA).&#xD;
&#xD;
      The secondary aims of this study, based on clinical exams and questionnaires are to evaluate&#xD;
      the quality of life, the patient activity and the sleep improvement after osteopathic&#xD;
      treatment, and to investigate if osteopathic medicine improves fatigue, comorbidities, and&#xD;
      decrease additional visits and medical investigations.&#xD;
&#xD;
      This study will also allow to identify the profile of the osteopathic treatment responders&#xD;
      patients&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">December 2, 2015</start_date>
  <completion_date type="Actual">July 27, 2018</completion_date>
  <primary_completion_date type="Actual">July 20, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Evaluation of pain during the 6 weeks of osteopathic treatment</measure>
    <time_frame>6 weeks</time_frame>
    <description>The assessment will be on the declarative of the patient. He will report every week the intensity of pain measured by a numeric scale (0 to 100).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Quality of life</measure>
    <time_frame>6 weeks after osteopathic treatment</time_frame>
    <description>Questionnaires: Fibromyalgia Impact Questionnaire (FIQ) and SF-36 (Short Form health survey)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life</measure>
    <time_frame>3 months after osteopathic treatment</time_frame>
    <description>Questionnaires: FIQ and SF-36</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life</measure>
    <time_frame>6 months after osteopathic treatment</time_frame>
    <description>Questionnaires: FIQ and SF-36</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life</measure>
    <time_frame>1 year after osteopathic treatment</time_frame>
    <description>Questionnaires: FIQ and SF-36</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fatigue</measure>
    <time_frame>6 weeks after osteopathic treatment</time_frame>
    <description>Questionnaires: multidimensional fatigue inventory (MFI) scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fatigue</measure>
    <time_frame>3 months after osteopathic treatment</time_frame>
    <description>Questionnaires: MFI scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fatigue</measure>
    <time_frame>6 months after osteopathic treatment</time_frame>
    <description>Questionnaires: MFI scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fatigue</measure>
    <time_frame>1 year after osteopathic treatment</time_frame>
    <description>Questionnaires: MFI scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain</measure>
    <time_frame>6 weeks after osteopathic treatment</time_frame>
    <description>Questionnaires: Brief Pain Inventory (BPI)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain</measure>
    <time_frame>3 months after osteopathic treatment</time_frame>
    <description>Questionnaires: BPI</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain</measure>
    <time_frame>6 months after osteopathic treatment</time_frame>
    <description>Questionnaires: BPI</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain</measure>
    <time_frame>1 year after osteopathic treatment</time_frame>
    <description>Questionnaires: BPI</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">101</enrollment>
  <condition>Fibromyalgia Syndrome</condition>
  <arm_group>
    <arm_group_label>Osteopathy +</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>75 patients will make 6 osteopathic sessions</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Osteopathy -</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>75 patients will make 6 factitious osteopathic sessions</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Osteopathic treatment</intervention_name>
    <description>osteopathic sessions of 20 minutes</description>
    <arm_group_label>Osteopathy +</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Factitious osteopathic treatment</intervention_name>
    <description>6 factitious osteopathic sessions of 20 minutes</description>
    <arm_group_label>Osteopathy -</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Patient Male or female aged at least of 18&#xD;
&#xD;
          2. Patient with fibromyalgia, according to the American College of Rheumatology (ACR)&#xD;
             1990 criteria, with a global level of pain of 50 over a 100 mm EVA scale&#xD;
&#xD;
          3. Patient suffering from fibromyalgia for over a year&#xD;
&#xD;
          4. Patient with stable medical/non medical treatment for at least 1 month before the&#xD;
             recruitment&#xD;
&#xD;
          5. Patient referred to a medical center for a multidisciplinary approach&#xD;
&#xD;
          6. Patient who can be followed for at least 12 months after the end of the osteopathic&#xD;
             sessions&#xD;
&#xD;
          7. Patient giving his informed consent to participate in the study&#xD;
&#xD;
          8. Patient affiliated to or beneficiary of social insurance&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Treatment by physical approach in progress or not older than 3 months : physiotherapy,&#xD;
             kinesitherapy, rehabilitation or manual treatment (osteopathic or chiropractic care,&#xD;
             manual medicine)&#xD;
&#xD;
          2. Unability to attend 6 sessions, meaning one weekly session, of osteopathy, at Hôtel&#xD;
             Dieu&#xD;
&#xD;
          3. Severe psychiatric pathology : major depression, psychosis&#xD;
&#xD;
          4. Pregnancy or breast feeding&#xD;
&#xD;
          5. The patient is already included in another clinical study&#xD;
&#xD;
          6. Patient under judicial protection&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Serge PERROT, PU-PH</last_name>
    <role>Principal Investigator</role>
    <affiliation>+ 33 1.42.34.84.49</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hotel-Dieu Hospital</name>
      <address>
        <city>Paris</city>
        <state>Ile-de-France</state>
        <zip>75004</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>April 2019</verification_date>
  <study_first_submitted>January 15, 2015</study_first_submitted>
  <study_first_submitted_qc>January 15, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 21, 2015</study_first_posted>
  <last_update_submitted>April 15, 2019</last_update_submitted>
  <last_update_submitted_qc>April 15, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">April 16, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Fibromyalgia syndrome</keyword>
  <keyword>pain</keyword>
  <keyword>quality of life</keyword>
  <keyword>osteopathic treatment</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fibromyalgia</mesh_term>
    <mesh_term>Myofascial Pain Syndromes</mesh_term>
    <mesh_term>Syndrome</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

